Your session is about to expire
← Back to Search
Opioid-sparing multimodal pain management for Postoperative Pain
N/A
Waitlist Available
Led By Silpa Nekkanti, MD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after the surgery on postoperative day 1 to 30
Awards & highlights
Study Summary
This trial is testing a new pain management protocol that includes ice therapy and scheduled opioid-sparing medications for pain control after minimally invasive gynecologic surgery.
Eligible Conditions
- Postoperative Pain
- Cryotherapy Effect
- Drug Abuse
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after the surgery on postoperative day 1 to 30
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after the surgery on postoperative day 1 to 30
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Day 1 pain score assessed by NRS-11
Secondary outcome measures
30-day postoperative outcomes
Adverse events (AEs)
Analgesic use - opioids measured by morphine equivalents
+11 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Novel multimodal protocol groupExperimental Treatment1 Intervention
They will receive scheduled topical ice therapy for 24 hours after surgery. It will be applied over abdominal incisions for 20 minutes every 2-3 hours. Acetaminophen and an NSAID will be scheduled for 96 hours. While inpatient, they will receive acetaminophen 975 mg every 8 hours and IV Toradol 15-30 mg every 6 hours with change to ibuprofen 800 mg every 8 hours when tolerating oral intake. They may take oxycodone 5 mg every 4-6 hours as needed (PRN) for breakthrough pain and pain score >6. They may use ice PRN after 24 hours. They will be prescribed acetaminophen 1000 mg every 8 hours and ibuprofen 800 mg every 8 hours for 96 hours postoperative. They may take them as needed after. If the participant used 0 narcotics in the first 24 hours, they will not be prescribed a narcotic. If up to 5 tablets were used, they will be prescribed 5 tablets of oxycodone 5 mg every 6 hours PRN. If more than 5 tablets were used, they will be prescribed 10 tablets of oxycodone 5 mg every 6 hours PRN.
Group II: Usual care protocol groupActive Control1 Intervention
Participants randomly assigned to the usual care protocol will receive current standard of care: scheduled acetaminophen and an NSAID for 24 hours. They will take acetaminophen 975 mg every 8 hours. They will also receive IV toradol 15 to 30 mg every 6 hours then switch to ibuprofen 800 mg every 8 hours when tolerating oral intake. They can also take oxycodone 5 mg every 4 to 6 hours on an as needed (PRN) basis for breakthrough pain with a pain score >6. Per our current standard of care, usual care participants will be allowed to use either topical heat or ice on an as needed basis during their recovery. On discharge home, they will be prescribed acetaminophen 1000 mg every 8 hours PRN and ibuprofen 800 mg every 8 hours PRN. They will also be prescribed 15 tablets of oxycodone 5 mg every 6 hours PRN.
Find a Location
Who is running the clinical trial?
Ohio State UniversityLead Sponsor
830 Previous Clinical Trials
505,690 Total Patients Enrolled
1 Trials studying Postoperative Pain
108 Patients Enrolled for Postoperative Pain
Silpa Nekkanti, MDPrincipal InvestigatorOhio State University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there an opportunity for new participants to join this research effort?
"Clinicaltrials.gov reports that enrollment for this trial is currently underway, having been announced on April 19th 2021 and updated most recently on April 20th 2022."
Answered by AI
How many individuals have been recruited for participation in this research?
"Affirmative. According to information found on clinicaltrials.gov, this medical trial is currently enrolling individuals as of April 20th 2022. The study was initiated in 2021 and requires 54 participants at a single location for completion."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger